MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617059653 A) filed by Fortvita Biologics Singapore Pte. Ltd. on May 11, 2026, for Anti-Il-4ra/Tslp Antibodies And Uses Thereof.
Inventors include Xiong, Yao; Li, Li; Zhou, Shuaixiang; Zhu, Mengzhu; and Fu, Jie.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: Provided are anti-IL-4Ra antibodies or antigen-binding fragments thereof, anti-TSLP antibodies or antigen-binding fragments thereof, antigen-binding protein constructs (e. g., multi-specific or bispecific antibodies capable of specifically binding to IL-4Ra and TSLP). Provided are polynucleotides encoding the antibodies or antigen-binding protein constructs, and expression vectors and host cells comprising the same. Also provided are immunoconjugates, pharmaceutical compositions and medicaments, as well as uses thereof for treating immune disorders (e.g., type II or mixed allergic diseases).
Disclaimer: Curated by HT Syndication.
